加拿大 - 英文 - Health Canada

jamp pharma corporation - linezolid - solution - 2mg - linezolid 2mg - oxazolidinones

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - linezolid - film-coated tablet - 600 milligram(s) - other antibacterials; linezolid

美国 - 英文 - NLM (National Library of Medicine)

mylan institutional llc - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid injection is indicated for the treatment of nosocomial pneumonia caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates) or streptococcus pneumoniae [see clinical studies (14)] . linezolid injection is indicated for the treatment of community-acquired pneumonia caused by streptococcus pneumoniae , including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible isolates only) [see clinical studies (14)] . linezolid injection is indicated for the treatment of complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis, caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus pyogenes , or streptococcus agalactiae . linezolid injection has not been studied in the treatment of decubitus ulcers [see clinical studies (14)] . linezolid injection is indicated for the treatment of uncomplicated skin and skin structure infections caused by staphylococcus

美国 - 英文 - NLM (National Library of Medicine)

american health packaging - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. linezolid is not indicated for the treatment of gram-negative infections. it is critical that specific gram-negative therapy be initiated immediately if a concomitant gram-negative pathogen is documented or suspected [see warnings and precautions (5.4)]. nosocomial pneumonia caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates) or streptococcus pneumoniae [see clinical studies (14)]. community-acquired pneumonia caused by streptococcus pneumoniae , including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible isolates only) [see clinical studies (14) ]. complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis, caused by staphylococcus aureus (methicillin-susceptible and -resistant isolat

美国 - 英文 - NLM (National Library of Medicine)

celltrion, inc. - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. linezolid is not indicated for the treatment of gram-negative infections. it is critical that specific gram-negative therapy be initiated immediately if a concomitant gram-negative pathogen is documented or suspected [see warnings and precautions (5.4) ]. nosocomial pneumonia caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates) or streptococcus pneumoniae [see clinical studies (14) ]. community-acquired pneumonia caused by streptococcus pneumoniae , including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible isolates only) [see clinical studies (14) ]. complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis , caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus pyogenes , or strept

美国 - 英文 - NLM (National Library of Medicine)

celltrion usa, inc. - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. linezolid is not indicated for the treatment of gram-negative infections. it is critical that specific gram-negative therapy be initiated immediately if a concomitant gram-negative pathogen is documented or suspected [see warnings and precautions (5.4) ]. nosocomial pneumonia caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates) or streptococcus pneumoniae [see clinical studies (14) ]. community-acquired pneumonia caused by streptococcus pneumoniae , including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible isolates only) [see clinical studies (14) ]. complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis , caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus pyogenes , or strept

比利时 - 英文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - linezolid 600 mg/300 ml - solution for infusion - 2 mg/ml - linezolid 2 mg/ml - linezolid

比利时 - 英文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - linezolid 2 mg/ml - solution for infusion - 2 mg/ml - linezolid 2 mg/ml - linezolid

比利时 - 英文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - linezolid 2 mg/ml - solution for infusion - 2 mg/ml - linezolid 2 mg/ml - linezolid